Advanced signet-ring cell carcinoma of the stomach: Clinicopathological characteristics of patients and efficacy of the modified docetaxel, cisplatin, and fluorouracil regimen

Bozkaya, Yakup; Erdem, Gokmen; Ozdemir, Nuriye; Hocazade, Cemil; Yazici, OZAN; Demirci, Nebi; Zengin, Nurullah

doi:10.4103/0973-1482.184514

Advanced signet-ring cell carcinoma of the stomach: Clinicopathological characteristics of patients and efficacy of the modified docetaxel, cisplatin, and fluorouracil regimen

Atıf İçin Kopyala

Bozkaya Y., Erdem G. U., Ozdemir N. Y., Hocazade C., Yazici O., Demirci N. S., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.14, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14
Basım Tarihi: 2018
Doi Numarası: 10.4103/0973-1482.184514
Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
Anahtar Kelimeler: Gastric cancer, modified docetaxel, cisplatin, and fluorouracil, prognosis, signet-ring cell carcinoma, ADVANCED GASTRIC-CANCER, 1ST-LINE TREATMENT, PROGNOSTIC VALUE, PHASE-III, ADENOCARCINOMA, HISTOLOGY, THERAPY, CLASSIFICATION, 5-FLUOROURACIL, CHEMOTHERAPY
Gazi Üniversitesi Adresli: Evet

Özet

Background: The aim of this retrospective study was to investigate the clinicopathological characteristics of patients with signet-ring cell carcinoma (SRCC) of the stomach, and the efficacy of the modified docetaxel, cisplatin, and fluorouracil (mDCF) chemotherapy regimen.